Study of Radiotherapy Combined With Platinum, Adebrelimab and Bevazumab in the Treatment of TNBC-BM.

Clinical trial NCT07638852 · RECRUITING

Trial details

NCT number: NCT07638852
Sponsor: Fudan University
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

TNBC, Triple Negative Breast Cancer Brain Metastasases

Start date: 2026-02-02
Primary completion: 2028-06-30
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.